RGNT REGENTIS BIOMATERIALS LTD. Annual reports only
Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1912966 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY—
TTM net income YoY-384.3%
TTM EPS YoY-1,504.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-337.0%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets37.7%
Debt / equity0.00x
Current ratio—
Interest coverage-88.20x
Cash quality & payout
Operating cash flow / net income0.10x
Accruals ratio-303.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | — | — | — |
| SG&A expense | $6.64M | $712,000 | $1.12M |
| Operating income | -$6.97M | $932,000 | -$1.93M |
| Interest expense | $79,000 | $10,000 | — |
| Pretax income | $13.65M | -$4.80M | $4.13M |
| Net income | -$13.65M | $4.80M | -$4.13M |
| EPS (basic) | -24.16 | 1.72 | -24.09 |
| EPS (diluted) | -24.16 | 1.72 | -24.09 |
| Weighted avg. shares (diluted) | 566,744 | 2.77M | 173,508 |
| Balance sheet | |||
| Cash & equivalents | $7.38M | — | — |
| Total assets | $7.62M | $482,000 | — |
| Current liabilities | $2.87M | $6.49M | — |
| Short-term debt | $1.20M | $573,000 | $210,000 |
| Total liabilities | $2.87M | $6.49M | — |
| Shareholders' equity | $4.74M | -$41.10M | -$45.91M |
| Shares outstanding | 5.18M | 162,198 | — |
| Cash flow statement | |||
| Operating cash flow | -$1.38M | -$641,000 | -$1.22M |
| Financing cash flow | $8.52M | $525,000 | $325,000 |
| Stock-based compensation | $7.04M | — | — |
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.